US Stock MarketDetailed Quotes

Sutro Biopharma (STRO)

Watchlist
  • 29.350
  • -0.420-1.41%
Close Apr 16 16:00 ET
  • 29.350
  • 0.0000.00%
Post 20:01 ET
486.25MMarket Cap-1.31P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sutro Biopharma (STRO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
65.18%102.48M
-21.35%11.65M
13.77%9.69M
147.98%63.75M
33.76%17.4M
-59.64%62.04M
-86.98%14.81M
-49.66%8.52M
146.89%25.71M
2.64%13.01M
Operating revenue
65.18%102.48M
-21.35%11.65M
13.77%9.69M
147.98%63.75M
33.76%17.4M
-59.64%62.04M
-86.98%14.81M
-49.66%8.52M
146.89%25.71M
2.64%13.01M
Cost of revenue
Gross profit
Operating expense
-30.97%207.44M
-43.42%45.3M
-36.43%48.59M
-34.58%48.67M
-6.79%64.87M
23.66%300.5M
13.46%80.07M
25.44%76.44M
31.45%74.39M
26.75%69.6M
Selling and administrative expenses
-15.34%41.02M
-4.08%8.66M
-39.01%8.74M
-16.39%10.34M
4.34%13.27M
-22.58%48.45M
-46.26%9.03M
-6.14%14.33M
-17.52%12.37M
-17.99%12.72M
-General and administrative expense
-15.34%41.02M
-4.08%8.66M
-39.01%8.74M
-16.39%10.34M
4.34%13.27M
-22.58%48.45M
-46.26%9.03M
-6.14%14.33M
-17.52%12.37M
-17.99%12.72M
Research and development costs
-33.97%166.42M
-48.42%36.64M
-35.83%39.85M
-38.21%38.33M
-9.28%51.6M
39.69%252.04M
32.12%71.04M
36.00%62.11M
49.12%62.02M
44.36%56.88M
Operating profit
55.99%-104.95M
48.42%-33.66M
42.72%-38.9M
130.97%15.08M
16.12%-47.47M
-167.09%-238.45M
-251.23%-65.26M
-54.31%-67.92M
-5.43%-48.69M
-33.98%-56.59M
Net non-operating interest income expense
-345.69%-32.81M
-82.09%-8.8M
-143.90%-8.4M
-97.73%-8.17M
-40.61%-7.45M
244.53%13.36M
-15.72%-4.83M
563.81%19.13M
-702.52%-4.13M
-1,144.37%-5.3M
Non-operating interest income
-79.18%9.25M
-60.26%1.53M
-92.57%2.01M
-48.71%2.52M
-22.14%3.19M
206.17%44.43M
-15.31%3.86M
494.33%27.04M
72.80%4.91M
60.00%4.1M
Non-operating interest expense
35.38%42.06M
18.86%10.33M
31.57%10.41M
18.21%10.69M
13.26%10.64M
30.82%31.07M
-0.48%8.69M
-8.82%7.91M
169.41%9.04M
214.70%9.4M
Other net income (expense)
-53.42M
-4.39M
-9.56M
-483.15%-18.42M
-671.98%-21.04M
-42.22%4.81M
152.62%3.68M
Gain on sale of security
----
----
----
----
----
----
----
----
-42.22%4.81M
152.62%3.68M
Special income (charges)
---53.42M
---4.39M
---9.56M
---18.42M
---21.04M
--0
--0
--0
--0
--0
-Less：Restructuring and merger&acquisition
--53.42M
--4.39M
--9.56M
--18.42M
--21.04M
--0
--0
--0
--0
--0
Income before tax
15.07%-191.18M
33.16%-46.84M
-16.54%-56.86M
76.01%-11.52M
-30.50%-75.97M
-154.06%-225.1M
-249.53%-70.09M
-2.83%-48.79M
-25.11%-48.01M
-17.23%-58.21M
Income tax
-103.94%-93K
-103.48%-82K
0
-325.00%-18K
-87.01%2.36M
-85.10%2.36M
0
-94.70%8K
0
Net income
15.99%-191.09M
35.45%-46.76M
-16.54%-56.86M
76.05%-11.5M
-30.50%-75.97M
-112.99%-227.46M
-333.20%-72.44M
1.01%-48.79M
-24.64%-48.02M
-16.31%-58.21M
Net income continuous Operations
15.99%-191.09M
35.45%-46.76M
-16.54%-56.86M
76.05%-11.5M
-30.50%-75.97M
-112.99%-227.46M
-333.20%-72.44M
1.01%-48.79M
-24.64%-48.02M
-16.31%-58.21M
Minority interest income
Net income attributable to the parent company
15.99%-191.09M
35.45%-46.76M
-16.54%-56.86M
76.05%-11.5M
-30.50%-75.97M
-112.99%-227.46M
-333.20%-72.44M
1.01%-48.79M
-24.64%-48.02M
-16.31%-58.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.99%-191.09M
35.45%-46.76M
-16.54%-56.86M
76.05%-11.5M
-30.50%-75.97M
-112.99%-227.46M
-333.20%-72.44M
1.01%-48.79M
-24.64%-48.02M
-16.31%-58.21M
Basic earnings per share
23.50%-22.49
38.05%-5.39
-13.56%-6.7
76.27%-1.4
4.21%-9.1
-65.17%-29.4
-267.31%-8.7
27.16%-5.9
7.81%-5.9
-11.76%-9.5
Diluted earnings per share
23.50%-22.49
38.05%-5.39
-13.56%-6.7
76.27%-1.4
4.21%-9.1
-65.17%-29.4
-267.31%-8.7
27.16%-5.9
7.81%-5.9
-11.76%-9.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 65.18%102.48M-21.35%11.65M13.77%9.69M147.98%63.75M33.76%17.4M-59.64%62.04M-86.98%14.81M-49.66%8.52M146.89%25.71M2.64%13.01M
Operating revenue 65.18%102.48M-21.35%11.65M13.77%9.69M147.98%63.75M33.76%17.4M-59.64%62.04M-86.98%14.81M-49.66%8.52M146.89%25.71M2.64%13.01M
Cost of revenue
Gross profit
Operating expense -30.97%207.44M-43.42%45.3M-36.43%48.59M-34.58%48.67M-6.79%64.87M23.66%300.5M13.46%80.07M25.44%76.44M31.45%74.39M26.75%69.6M
Selling and administrative expenses -15.34%41.02M-4.08%8.66M-39.01%8.74M-16.39%10.34M4.34%13.27M-22.58%48.45M-46.26%9.03M-6.14%14.33M-17.52%12.37M-17.99%12.72M
-General and administrative expense -15.34%41.02M-4.08%8.66M-39.01%8.74M-16.39%10.34M4.34%13.27M-22.58%48.45M-46.26%9.03M-6.14%14.33M-17.52%12.37M-17.99%12.72M
Research and development costs -33.97%166.42M-48.42%36.64M-35.83%39.85M-38.21%38.33M-9.28%51.6M39.69%252.04M32.12%71.04M36.00%62.11M49.12%62.02M44.36%56.88M
Operating profit 55.99%-104.95M48.42%-33.66M42.72%-38.9M130.97%15.08M16.12%-47.47M-167.09%-238.45M-251.23%-65.26M-54.31%-67.92M-5.43%-48.69M-33.98%-56.59M
Net non-operating interest income expense -345.69%-32.81M-82.09%-8.8M-143.90%-8.4M-97.73%-8.17M-40.61%-7.45M244.53%13.36M-15.72%-4.83M563.81%19.13M-702.52%-4.13M-1,144.37%-5.3M
Non-operating interest income -79.18%9.25M-60.26%1.53M-92.57%2.01M-48.71%2.52M-22.14%3.19M206.17%44.43M-15.31%3.86M494.33%27.04M72.80%4.91M60.00%4.1M
Non-operating interest expense 35.38%42.06M18.86%10.33M31.57%10.41M18.21%10.69M13.26%10.64M30.82%31.07M-0.48%8.69M-8.82%7.91M169.41%9.04M214.70%9.4M
Other net income (expense) -53.42M-4.39M-9.56M-483.15%-18.42M-671.98%-21.04M-42.22%4.81M152.62%3.68M
Gain on sale of security ---------------------------------42.22%4.81M152.62%3.68M
Special income (charges) ---53.42M---4.39M---9.56M---18.42M---21.04M--0--0--0--0--0
-Less：Restructuring and merger&acquisition --53.42M--4.39M--9.56M--18.42M--21.04M--0--0--0--0--0
Income before tax 15.07%-191.18M33.16%-46.84M-16.54%-56.86M76.01%-11.52M-30.50%-75.97M-154.06%-225.1M-249.53%-70.09M-2.83%-48.79M-25.11%-48.01M-17.23%-58.21M
Income tax -103.94%-93K-103.48%-82K0-325.00%-18K-87.01%2.36M-85.10%2.36M0-94.70%8K0
Net income 15.99%-191.09M35.45%-46.76M-16.54%-56.86M76.05%-11.5M-30.50%-75.97M-112.99%-227.46M-333.20%-72.44M1.01%-48.79M-24.64%-48.02M-16.31%-58.21M
Net income continuous Operations 15.99%-191.09M35.45%-46.76M-16.54%-56.86M76.05%-11.5M-30.50%-75.97M-112.99%-227.46M-333.20%-72.44M1.01%-48.79M-24.64%-48.02M-16.31%-58.21M
Minority interest income
Net income attributable to the parent company 15.99%-191.09M35.45%-46.76M-16.54%-56.86M76.05%-11.5M-30.50%-75.97M-112.99%-227.46M-333.20%-72.44M1.01%-48.79M-24.64%-48.02M-16.31%-58.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.99%-191.09M35.45%-46.76M-16.54%-56.86M76.05%-11.5M-30.50%-75.97M-112.99%-227.46M-333.20%-72.44M1.01%-48.79M-24.64%-48.02M-16.31%-58.21M
Basic earnings per share 23.50%-22.4938.05%-5.39-13.56%-6.776.27%-1.44.21%-9.1-65.17%-29.4-267.31%-8.727.16%-5.97.81%-5.9-11.76%-9.5
Diluted earnings per share 23.50%-22.4938.05%-5.39-13.56%-6.776.27%-1.44.21%-9.1-65.17%-29.4-267.31%-8.727.16%-5.97.81%-5.9-11.76%-9.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -